( As on 04/12/2025 13:17)
Lupin Limited has informed the Exchange regarding a press release dated December 04, 2025, titled ""Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States"".